Seer, Inc. financial data

Symbol
SEER on Nasdaq
Location
3800 Bridge Parkway, Suite 102, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Seer Biosciences, Inc. (to 1/4/2018)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.34K % -20.8%
Quick Ratio 39.8 % +9.47%
Debt-to-equity 10.2 % +8.13%
Return On Equity -21.3 % +0.61%
Return On Assets -19.3 % +1.33%
Operating Margin -681 % -7.39%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 64M shares +2.14%
Entity Public Float 232M USD -45.5%
Weighted Average Number of Shares Outstanding, Basic 64.6M shares +1.28%
Weighted Average Number of Shares Outstanding, Diluted 64.6M shares +1.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.7M USD -11.3%
Cost of Revenue 7.49M USD -6.76%
Research and Development Expense 49.4M USD -6.48%
General and Administrative Expense 14.8M USD -4.39%
Operating Income (Loss) -100M USD +4.78%
Nonoperating Income (Expense) 17.9M USD +56%
Net Income (Loss) Attributable to Parent -82.4M USD +12.2%
Earnings Per Share, Basic -1.27 USD/shares +14.8%
Earnings Per Share, Diluted -1.27 USD/shares +14.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.9M USD -43.4%
Cash, Cash Equivalents, and Short-term Investments 284M USD -11.5%
Accounts Receivable, after Allowance for Credit Loss, Current 4.83M USD +12%
Inventory, Net 7.58M USD +44%
Assets, Current 300M USD -10.6%
Property, Plant and Equipment, Net 20.4M USD -7.63%
Operating Lease, Right-of-Use Asset 24M USD -9.13%
Other Assets, Noncurrent 818K USD -18%
Assets 407M USD -11.8%
Accrued Liabilities, Current 9.82M USD +23.8%
Contract with Customer, Liability, Current 189K USD -25.9%
Liabilities, Current 17M USD +7.8%
Operating Lease, Liability, Noncurrent 24.8M USD -8.36%
Other Liabilities, Noncurrent 44K USD -74.7%
Liabilities 41.9M USD -2.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -626K USD +59.1%
Retained Earnings (Accumulated Deficit) -349M USD -30.9%
Stockholders' Equity Attributable to Parent 365M USD -12.8%
Liabilities and Equity 407M USD -11.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.5M USD +45.9%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 32.4M USD +123%
Common Stock, Shares Authorized 105M shares 0%
Common Stock, Shares, Issued 64M shares +2.14%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.5M USD -43%
Deferred Tax Assets, Valuation Allowance 74M USD +34.6%
Deferred Tax Assets, Gross 81M USD +30.3%
Operating Lease, Liability 27.1M USD -7.66%
Depreciation 6.1M USD +32.6%
Payments to Acquire Property, Plant, and Equipment 754K USD +523%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -81.5M USD +11.7%
Lessee, Operating Lease, Liability, to be Paid 34.9M USD -10.3%
Property, Plant and Equipment, Gross 35.9M USD +12.9%
Operating Lease, Liability, Current 2.27M USD +0.71%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.96M USD +2.89%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.85M USD -3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.8M USD -18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.07M USD +2.91%
Deferred Tax Assets, Operating Loss Carryforwards 41.2M USD +24.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.36M USD +49.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.19M USD +2.92%
Operating Lease, Payments 1.01M USD +2.65%
Additional Paid in Capital 715M USD +4.09%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 7.14M USD +22.5%
Share-based Payment Arrangement, Expense 31.2M USD -12.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%